71
72
73
74
75
Zeevat, Florian, Crepey, Pascal, Dolk, F. Christiaan K., Postma, Arjan J., Breeveld-Dwarkasing, Vidya N. A., Postma, Maarten J.
Veröffentlicht in: Zeevat , F , Crepey , P , Dolk , F C K , Postma , A J , Breeveld-Dwarkasing , V N A & Postma , M J 2021 , ' Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program ' , Value in Health , vol. 24 , no. 1 , pp. 3-10 . https://doi.org/10.1016/j.jval.2020.11.002;
2021
Veröffentlicht in: Zeevat , F , Crepey , P , Dolk , F C K , Postma , A J , Breeveld-Dwarkasing , V N A & Postma , M J 2021 , ' Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program ' , Value in Health , vol. 24 , no. 1 , pp. 3-10 . https://doi.org/10.1016/j.jval.2020.11.002;
2021
76
77
78
79
Le, Hoa H., Hodgkins, Paul, Postma, Maarten J., Kahle, Jennifer, Sikirica, Vanja, Setyawan, Juliana, Erder, M. Haim, Doshi, Jalpa A.
Veröffentlicht in: Le , H H , Hodgkins , P , Postma , M J , Kahle , J , Sikirica , V , Setyawan , J , Erder , M H & Doshi , J A 2014 , ' Economic impact of childhood/adolescent ADHD in a European setting : the Netherlands as a reference case ' , European Child & Adolescent Psychiatry , vol. 23 , no. 7 , pp. 587-598 . https://doi.org/10.1007/s00787-013-0477-8;
2014
Veröffentlicht in: Le , H H , Hodgkins , P , Postma , M J , Kahle , J , Sikirica , V , Setyawan , J , Erder , M H & Doshi , J A 2014 , ' Economic impact of childhood/adolescent ADHD in a European setting : the Netherlands as a reference case ' , European Child & Adolescent Psychiatry , vol. 23 , no. 7 , pp. 587-598 . https://doi.org/10.1007/s00787-013-0477-8;
2014
80
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018